The workplace project – putting learning into practice

Taking practical education to a fundamental level, every two-module MasterClass includes an intermodule project as a mandatory part of the course. An opportunity to test new knowledge and skills and to improve local services, delegates are offered mentorship and encouraged to support their peers as they continue to develop their specialism in a way that directly impacts their patient's outcomes.

Attendees have free reign over this project. It might be service delivery, patient management or drug treatments, and it could take the form of a service description, an audit, or another form of research. It should meet a local need.

When complete, the project closes with a presentation to the other course members, faculty, and often their managers, commissioners or other people of influence in their area. The group chooses a winner and runner up who receive an award at an evening event.


Spotlight projects


Siponimod use in Northern Ireland
By Conor Hughes, Clinical fellow, Royal Victoria Hospital
Improving Introductory communication for advanced MS clinics
By Dr Sophie Mullins, SPR neuropalliative fellow, Southmead Hospital, North Bristol NHS Trust.
Reducing time to Disease-Modifying-Therapy initiation via homecare
By Sukhi Chahal, Advanced clinical pharmacist - MS & neurosciences, Oxford University Hospitals NHS Foundation Trust
Optimising MS Nurse Reviews - Shifting Towards a More Patient-Focused Approach
By Denisse Bongol, Clinical nurse specialist, MS, University College London Hospitals NHS Foundation Trust & Jessica Mensah, Pharmacist, University College London Hospitals NHS Foundation Trust

All projects


Showing 19-27 of 62 projects

Safety of Cladribine in people with MS treated in a district general hospital: Audit Report
By Dr Chamila Perera, Senior Clinical Fellow in Neurology, Bedford Hospital NHS Trust
Nabilone, a CB1 agonist, for managing multiple sclerosis symptoms
By Dr Filipa Serrazina, Neurology Resident, Barts Health NHS Trust
How Frequently Should Immunoglobulin Levels be Monitored in Patients with Multiple Sclerosis receiving Ocrelizumab?
By Dr Trisha Mukherjee, Neurology Specialist Registrar ST5, University College London Hospitals NHS Foundation Trust & Dr Cyrus Daruwalla, Neurology Specialist Registrar, Cambridge University Hospitals NHS Foundation Trust
Initiating a new Disease Modifying Treatment (DMT) into an existing service
By Sarah Hughes, Multiple Sclerosis Specialist Nurse, Torbay and South Devon NHS Foundation Trust
Reducing Delays to DMT Initiation via Homecare Prescriptions in Multiple Sclerosis
By Rebecca Harrison, Specialist Pharmacist for Neurology & Stroke Band 8, Royal United Hospitals Bath NHS Foundation Trust
Reducing treatment waiting times
By Lynn Bezance, MS Specialist Nurse, South Tees Hospitals NHS Foundation Trust
Setting up a Complex Disease Modifying Drug (DMD) Switching Clinic
By Aoife Shields, MS Principal Pharmacist, University College London Hospitals NHS Foundation Trust
A model of care for subcutaneous Natalizumab in the community
By Sinead Jordan, MS Clinical Nurse Specialist, St Vincents's University Hospital